Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease

BACKGROUND: The development of disease-modifying therapies for Alzheimer’s disease is hampered by our lack of understanding of the early pathogenic mechanisms and the lack of early biomarkers and risk factors. We have documented the expression pattern of mTOR regulated genes in the frontal cortex of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, Sharon C, Zafar, Amen, Hubbard, Paul, Nagy, Sheila, Durant, Sarah, Bicknell, Roy, Wilcock, Gordon, Christie, Sharon, Esiri, Margaret M, Smith, A David, Nagy, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776211/
https://www.ncbi.nlm.nih.gov/pubmed/24252508
http://dx.doi.org/10.1186/2051-5960-1-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776211/
https://www.ncbi.nlm.nih.gov/pubmed/24252508
http://dx.doi.org/10.1186/2051-5960-1-3

Ejemplares similares